Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin

Phase 3

Completed

• Conditions: Type 2 Diabetes Mellitus

• Registration Number: NCT00213122
• Lead Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd.

Brief Summary

In this study, the effect of miglitol on daily plasma glucose will be evaluated in type 2 diabetic patients treated with insulin.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-21
• Status Verified: 2006-09
• Last Update Submitted: 2006-09-25
• Last Update Posted: 2006-09-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• type2 diabetes
• postprandial plasma glucose levels ≧180mg/dl

Exclusion Criteria

• type1 diabetes
• AST(GOT) or ALT(GPT) ≧100IU/l
• creatinine ≧2.0mg/dl

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER